RecruitingNCT07421765

Interaction Between Atypical Work Schedules and/or Idel Time at Work on At-risk Gambling Practices

Evaluation de l'Interaction Entre Les Horaires Atypiques et/ou Les Temps d'inactivité Sur Les Pratiques de Jeu à Risque Chez Les Adultes Travaillant Dans Ces Conditions


Sponsor

Centre Hospitalier Universitaire de Nīmes

Enrollment

25 participants

Start Date

Feb 5, 2026

Study Type

OBSERVATIONAL

Conditions

Summary

At-risk gambling causes individual and social harm, influenced by environmental, psychological, and socioeconomic factors. In France, 5% of adult gamblers show at-risk gambling practices. Atypical work schedules and idle time at work could increase this risk, but few studies have explored this. These working conditions impact the mental and cognitive health of workers, potentially contributing to at-risk gambling, especially during periods of idle time The study authors wish to explore the links between atypical work schedules, idle time at work, and at-risk gambling practices, considering social norms and individual vulnerabilities.


Eligibility

Min Age: 18 Years

Inclusion Criteria3

  • Living with current or remission gambling, as assessed using the Problem Gambling Index Scale (PGSI) score of ≥5
  • Having been employed during the current year
  • Patients with a personal mobile phone number and email address who agree to share them for research

Exclusion Criteria2

  • Patient in an exclusion period determined by another study
  • Patient who has expressed their opposition to participating in this research

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

OTHERsemi-structured interview

After having completed a consent form and online self-questionnaires, participants will take part in online interviews lasting 45 to 60 minutes


Locations(2)

CHU de Nantes

Nantes, France

CHU de Nîmes

Nîmes, France

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT07421765


Related Trials